Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desvenlafaxine for Opioid-Dependent Patients With Comorbid Depression
NCT02200406Phase 4Completed
- Sponsor
- Centre hospitalier de l’Université de Montréal
- Start
- Jul 2014
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of desvenlafaxine in major depressive disorder (MDD), sponsored by Centre hospitalier de l’Université de Montréal. Started Jul 2014; status: completed.
02
Drugs
desvenlafaxine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02200406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02200406.